Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

312.16 -2.08 (-0.66%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
These stocks have something to offer every type of investor. 
Via The Motley Fool
Got $1,500? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
These companies are raking in profits and growing at a speed that outpaces the competition. 
Via The Motley Fool
2 No-Brainer Growth Stocks to Buy Right Now
Don't let these incredible businesses pass you by. 
Via The Motley Fool
A Recession Could Be More Likely Now: Here's What Investors Should Do
There's one strategy that's the best approach of all. 
Via The Motley Fool
3 Top Stocks to Buy and Hold for the Next Decade and Beyond
The sky is the limit for these stocks. 
Via The Motley Fool
Chances of a New Bull Market Fading? 2 Great Stocks to Buy Anyway
These two stocks are unstoppable leaders. 
Via The Motley Fool
2 Biotech Stocks That Could Help Set You Up for Life
The two companies have seen similar share growth over the past year. 
Via The Motley Fool
2 Top Biotech Stocks Defying the Bear Market
These stocks soared in the double digits last year. 
Via The Motley Fool
2 Monster Stocks to Buy Hand Over Fist in 2023
A pandemic favorite and a healthcare growth stock each have something to add to the long-term investor's portfolio. 
Via The Motley Fool
Robinhood, Merck And 2 Other Stocks Insiders Are Selling
The Nasdaq closed higher by around 0.6% on Tuesday, also recording losses for the week. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
3 Prime Healthcare Takeover Targets
These three companies are attractive targets for their potential. 
Via The Motley Fool
Large-Cap Biopharmaceuticals: Bearish Sentiment Curbs Buyers
Large cap biopharma stocks are off their highs despite reasonable valuations plus dividends. 
Via Talk Markets
ARK Invest: The 7 Words That Explain Why Wall Street Can’t Stand Cathie Wood
Why does Wall Street hate Cathie Wood and her ARKK ETF? Seven words show how her focus on innovation divides investors. 
Via InvestorPlace
3 Growth Stocks With More Potential Than Any Cryptocurrency
Setting your portfolio up for robust long-term returns doesn't have to be complicated. 
Via The Motley Fool
2 Top Healthcare Stocks to Buy for the Long Haul
The healthcare industry is booming, and this presents no shortage of opportunities to invest in promising businesses. 
Via The Motley Fool
3 Unstoppable Growth Stocks to Buy for 2023 and Beyond
The future looks really bright for these businesses -- and their stocks. 
Via The Motley Fool
2 Top Stocks to Buy in February and Hold Forever
These healthcare giants are profitable and have wide moats. 
Via The Motley Fool
The Best Stocks To Invest $5,000 in Right Now
The time is right for each of these great stocks. 
Via The Motley Fool
These Cheap Growth Stocks Could Supercharge Your Portfolio
All of these players are cheap today considering their growth potential. 
Via The Motley Fool
3 Surefire Growth Stocks You Can Buy Right Now
Maybe there's no such thing as a sure thing. But these stocks could come close. 
Via The Motley Fool
This Growth Stock Crushed the Market Last Year. 5 Words from the CEO Suggest There's More to Come.
Vertex climbed 31% last year even as the overall market fell. 
Via The Motley Fool
Stock Market Pulls Back As Treasury Yields Jump; Google Dives On AI Flop: Weekly Review
Is this a normal, healthy pullback or the start of something more? 
Via Investor's Business Daily
3 Stocks That Could Soar Whether There's a New Bull Market or Not
These stocks could enjoy their own bull markets regardless of what the overall market does. 
Via The Motley Fool
2 Top Stocks to Buy Without Hesitation in 2023
These healthcare giants have a long track record of enriching investors. 
Via The Motley Fool
Is Vertex Pharmaceuticals Stock a Buy Right Now?
The drugmaker outperformed the broad market by a mile in 2022, but could there be further gains? 
Via The Motley Fool
Better Bull Market Buy: CRISPR Therapeutics or Vertex Pharmaceuticals?
Both stocks should be winners if gene-editing therapy exa-cel wins regulatory approvals. 
Via The Motley Fool
What's Going On With Vertex Pharmaceuticals (VRTX) Stock Wednesday?
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares are trading lower by 1.44% to $304.10 Wednesday morning. The company on Tuesday reported fourth-quarter financial results. What Happened? 
Via Benzinga
1 Beaten-Down Stock That Has a Lot to Prove in 2023
This biotech looks like a high-risk, high-reward play. 
Via The Motley Fool
Vertex Pharmaceuticals (VRTX) Q4 2022 Earnings Call Transcript
VRTX earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Why Vertex Pharmaceuticals Stock Is Moving During Tuesday's After-Hours Session
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) shares are trading marginally lower by 0.82% to $306 during Tuesday's after-hours session. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.